Homing agents

US11052163B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11052163-B2
Application numberUS-201715711780-A
CountryUS
Kind codeB2
Filing dateSep 21, 2017
Priority dateMay 3, 2013
Publication dateJul 6, 2021
Grant dateJul 6, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides peptide constructs for diagnostic imaging and therapeutic applications, using pegylated peptides which exhibit specific binding for a target molecule of interest, such as a biomarker of a disease or disorder.

First claim

Opening claim text (preview).

What is claimed is: 1. A p-armed multimer, wherein p is 4 and each arm of the multimer comprises: a polymer comprising n PEG monomers, wherein n is 9; a homing molecule that is SEQ ID NO: 1; a chelating agent that is N2S2; and a linker consisting of glutamic acid; wherein the polymer, the homing molecule and the chelating agent are each attached to the linker and wherein at least one of the polymer, the homing molecule or the chelating agent is attached to a side chain of an amino acid in the linker; and wherein each arm of the multimer is bound to the other arms of the multimer via an end of the polymer not attached to the linker. 2. A p-armed multimer of claim 1 , wherein the amino acid side chain is directly attached to one of the polymer, homing molecule or chelating agent. 3. A p-armed multimer of claim 1 , wherein the amino acid side chain is attached via click chemistry to one of the polymer, homing molecule or chelating agent. 4. A p-armed multimer of claim 1 , wherein the homing molecule is linked to the C-terminus of glutamic acid, and the polymer is linked via an amino acid side chain of glutamic acid. 5. A p-armed multimer of claim 1 , further comprising a radionuclide bonded to the chelating agent on at least one arm. 6. A p-armed multimer of claim 5 , further comprising a radionuclide bonded to the chelating agent on at least one arm. 7. A radiopharmaceutical composition comprising a p-armed multimer of claim 5 , together with a pharmaceutically-acceptable carrier. 8. A p-armed multimer of claim 1 , wherein the homing molecule is attached to the linker via a hydrophilic moiety. 9. A method for detecting intradevice thrombus in a subject having an implanted mechanical circulation assist device, the method comprising: (a) administering into the bloodstream of the subject an effective amount of a p-armed multimer of claim 5 ; (b) allowing the p-armed multimer to bind thrombus; and (c) detecting a signal from the radionuclide of the p-armed multimer localized at a site of thrombus. 10. The method of claim 9 , wherein the method further comprises quantifying intradevice thrombus by: (d) determining the amount of p-armed multimer localized at a site of thrombus from the signal detected, wherein the amount of p-armed multimer is indicative of the size of the thrombus.

Assignees

Inventors

Classifications

  • conjugated systems · CPC title

  • having 5 to 11 amino acids · CPC title

  • Methine dyes, e.g. cyanine dyes · CPC title

  • conjugates with carriers being macromolecules · CPC title

  • A61K51/088Primary

    conjugates with carriers being peptides, polyamino acids or proteins (antibodies A61K51/10) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11052163B2 cover?
The present disclosure provides peptide constructs for diagnostic imaging and therapeutic applications, using pegylated peptides which exhibit specific binding for a target molecule of interest, such as a biomarker of a disease or disorder.
Who is the assignee on this patent?
Lanza Gregory M, Achilefu Samuel I, Hufang Cui Grace, and 1 more
What technology area does this patent fall under?
Primary CPC classification A61K51/088. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).